Search
for
Sort by
Research 601–630 of 1000+
- Central hair loss in African American women: Incidence and potential risk factors
- Hair loss at 20 associated with prostate cancer risk later in life
- Faculty Opinions recommendation of Association between 5-alpha reductase inhibition and risk of hip fracture.
- Finasteride chemoprevention might be cost-effective in high-risk populations
- A Case-Control Study of Physical Activity, Obesity and Energy intake and the Risk of Kidney Cancer
- Phosphodiesterase inhibitors used in androgenic alopecia as a possible risk factor for testicular tumor
- A study on relationship between androgenetic alopecia and cardiovascular risk using high sensitivity C-reactive protein and galectin-3 in men with early onset baldness.
- MTHFR C677T Polymorphism and Serum Homocysteine Level as Risk Factors of Coronary Heart Disease in Patients with Androgenetic Alopecia: A Case Control Study
- Low quality of life and high HSS‐29 scores reflect the risk of loss to follow‐up: a study in patients with androgenetic alopecia
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- Dutasteride, finasteride: no increased risk of ED
- 341 ANDROGENETIC ALOPECIA AT VARIOUS AGES AND PROSTATE CANCER RISK IN AN EQUAL ACCESS MULTIETHNIC CASE CONTROL SERIES OF VETERANS
- Faculty Opinions recommendation of Androgen receptor gene polymorphisms and risk for androgenetic alopecia: a meta-analysis.
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Correlation between Androgenetic Alopecia and Lipid Parameters for Risk Factors of Coronary Artery Disease
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: A prospective controlled study
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Low fluence-high repetition rate diode laser hair removal 12-month evaluation: Reducing pain and risks while keeping clinical efficacy
- Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
- Association between <i>VEGF</i> gene polymorphisms (11 sites) and polycystic ovary syndrome risk
- Cutaneous melanoma, prostate-specific antigen testing and the subsequent risk of prostate cancer diagnosis: a prospective analysis of the 45 and Up Study
- Pediatric androgenetic alopecia: a retrospective review of clinical characteristics, hormonal assays and metabolic syndrome risk factors in 23 patients
- Periocular nasociliary lesion with elevated serum IgG4 levels: A case report on the risks of overdiagnosis in IgG4-related disease
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Research on the Mechanism of Hair Dyeing Agents and Strategies for Health Risks Reduction